AI jitters are turning discount chains and shampoo makers into the stock market's hottest trade - and that's risky
Consumer staples, long seen as a safety play when tech stocks sell off, are now among the riskier bets on Wall Street.
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
ADA
LEO
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
ADA
LEO
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
ADA
LEO
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
ADA
LEO
L1 Capital, an investment management firm, released its "L1 Capital International Fund" (unhedged) fourth-quarter 2025 investor letter. A copy of the lette...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse ArticlesConsumer staples, long seen as a safety play when tech stocks sell off, are now among the riskier bets on Wall Street.
The healthcare that patients get before and after a stroke depends largely on the insurance they have - highlighting the differences between Medicare Advan...
Novo Nordisk's study showing a new drug wasn't as good as a rival's led one sell-side analyst to downgrade the stock for the first time in five years.
Ford recalls over 412,000 Explorer vehicles due to suspension issue
These top brands are undervalued.
This biotech powerhouse could maintain its strength for the long term.
Paramount submits higher offer for Warner Bros Discovery in bid to block Netflix, source says
Ford to recall about 413,000 SUVs in US over potential loss of steering control, NHTSA says
European shares slip as trade uncertainty, AI-disruption fears weigh
Political expediency in the White House means sacrificing bond investors to achieve electoral success
Palantir is growing fast and printing profits, but the stock is still priced for years of near-perfect execution.
The wellness platform's results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business.